Histological progression of chronic renal allograft injury comparing sirolimus and mycophenolate mofetil-based protocols. A single-center, prospective, randomized, controlled study-Reference-Cited by-同舟云学术

Histological progression of chronic renal allograft injury comparing sirolimus and mycophenolate mofetil-based protocols. A single-center, prospective, randomized, controlled study

Published:2010-09-29 Issue:7 Volume:14 Page:909-918
ISSN:1397-3142
Container-title:Pediatric Transplantation
language:en
Short-container-title:

Author:

Blydt-Hansen Tom D.,Gibson Ian W.,Birk Patricia E.

Publisher

Wiley

Subject

Transplantation,Pediatrics, Perinatology and Child Health

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1399-3046.2010.01374.x/fullpdf

Reference44 articles.

1. A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group;Pirsch;Transplantation,1997

2. Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. U.S. Renal Transplant Mycophenolate Mofetil Study Group;Sollinger;Transplantation,1995

3. The impact of acute rejection on chronic rejection: A report of the North American Pediatric Renal Transplant Cooperative Study;Tejani;Pediatr Transplant,2000

4. NAPRTCS Annual report, 2008 https://web.emmes.com/study/ped/annlrept/Annual%20Report%20-2008.pdf

5. Variables affecting estimated glomerular filtration rate after renal transplantation in children: A NAPRTCS data analysis;Moudgil;Pediatr Transplant,2010

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety Evaluation of Oral Sirolimus in the Treatment of Childhood Diseases: A Systematic Review;Children;2022-08-26

2. Induction and Standard Immunosuppression;Solid Organ Transplantation in Infants and Children;2018

3. Induction and Standard Immunosuppression;Solid Organ Transplantation in Infants and Children;2017

4. Chronic Renal Transplant Dysfunction;Pediatric Kidney Disease;2016

5. Cellular and molecular immune profiles in renal transplant recipients after conversion from tacrolimus to sirolimus;Kidney International;2015-04